MedPath

Flemish Inguinal and Femoral Hernia Prospective Registry

Recruiting
Conditions
Inguinal Hernia
Interventions
Device: Surgical inguinal or femoral hernia repair
Registration Number
NCT04623580
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

Prospective registry. The purpose of this clinical trial will be to measure surgical outcome parameters (e.g. recurrence, chronic pain and other quality indicators) after inguinal hernia repair using Patient Reported Outcome Measures (PROMs) in the short- and long-term.

Detailed Description

The primary objective is to investigate moderate to severe chronic pain 1 year after inguinal or femoral hernia repair, defined as numeric rating scale (NRS) ≥ 4, during daily activities.

The secondary objectives are:

* Surgical Site Occurrence (SSO) after 30 days

* Scope and incidence of pre- and postoperative pain (NRS 0 to 10)

* The difference between pre- and postoperative NRS scores (relative NRS score)

* Presence of pain and impact of pain on daily life activities

* Satisfaction and quality of life

* Sexual function

* Anxiety and depression

* Catastrophizing

* Recurrence

* Development of a predictive model for chronic pain.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
560
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Inguinal or femoral hernia repairSurgical inguinal or femoral hernia repairAll consecutive inguinal or femoral hernia repair (primary or mesh)
Primary Outcome Measures
NameTimeMethod
Chronic pain after inguinal hernia repair5 years

To investigate moderate to severe chronic pain 1 year after inguinal or femoral hernia repair, defined as numeric rating scale (NRS) ≥ 4, during daily activities.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Colette Barlé

🇧🇪

Leuven, Belgium

UZ Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath